For patients with blood cancer, the completion of chemotherapy is only the beginning of a long journey. Monthly monitoring of blood and bone marrow for signs of recurring cancer can extend for several years. Adaptive Biotechnologies asked Traina to develop a campaign that helps patients understand the various cancer detection methods, and introduces a revolutionary new technology called MRD Testing. Launched in late 2016, the KnowMRD campaign has already touched thousands of patients worldwide.